Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
PharmaIN
AddedFeb 16, 2024
UpdatedJun 18, 2026
PharmaIN

PharmaIN

Seed

PharmaIN, a US-based biopharmaceutical firm, enhances injectable therapeutics via patented PGC™ technology.

HQ
Bothell, WA, US
Founded
2001
Overview
Compare
Fundraising
Employees
Website

PharmaIN, founded in Bothell, United States, is a development-stage biopharmaceutical company dedicated to enhancing injectable therapeutics through its proprietary Protected Graft Copolymer (PGC™) technology. This technology, licensed from Massachusetts General Hospital, aims to extend the half-life and improve the targeted delivery of proteins, peptides, siRNA, and potent small molecule therapeutics. PharmaIN's market focus includes addressing critical needs in drug delivery systems to improve patient outcomes.

Notable affiliations include Massachusetts General Hospital, from which PharmaIN licenses its core technology. Key achievements involve the development of investigational drug therapies like PHIN-214, although these have not yet received FDA approval. The company's impact lies in its innovative approach to drug delivery, potentially transforming therapeutic efficacy and patient care in the biopharmaceutical industry.

PharmaIN - Similar Companies

Pinpoint Pharma logo

Pinpoint Pharma

pinpointpharma.co

PIN Pharma logo

PIN Pharma

pinpharma.com

pH Pharma logo

pH Pharma

ph-pharma.com

Ziran Biopharmaceutical logo

Ziran Biopharmaceutical

BioQ Pharma logo

BioQ Pharma

bioqpharma.com

InSitu Biologics logo

InSitu Biologics

Prometheon Pharma logo

Prometheon Pharma

InpharmD logo

InpharmD

inpharmd.com

Trilogic Pharma logo

Trilogic Pharma

trilogicpharma.com

Pharmatrophix logo

Pharmatrophix

pharmatrophix.com

Inipharm logo

Inipharm

inipharm.com

BiotechInnova logo

BiotechInnova

biotechinnova.com

iCeutica logo

iCeutica

Phoreus Biotechnology logo

Phoreus Biotechnology

phoreusbiotech.com

Protect Pharmaceutical logo

Protect Pharmaceutical

PharmaIN - Quick Facts

Who are PharmaIN's competitors?

Companies similar to PharmaIN include Pinpoint Pharma, PIN Pharma, pH Pharma and Ziran Biopharmaceutical.

When was PharmaIN founded?

PharmaIN was founded in 2001.

Where is PharmaIN's headquarters located?

PharmaIN's headquarters is located in Bothell, WA, US.

When was PharmaIN's last funding round?

PharmaIN's most recent funding round was for $1.5M (USD) in May 2014.

How much has PharmaIN raised to-date?

As of May 16, 2014, PharmaIN has raised a total of $1.5M (USD).

How many employees does PharmaIN have?

PharmaIN has 18 employees as of Feb 4, 2024.

PharmaIN - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Delivery
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified